Boten Co., Ltd.: direnavir API has passed who PQ certification
Cailian news agency, Nov. 29 - boten announced that recently, the company received the PQ (pre certification) confirmation letter (CPQ) issued by who. The company's direnavir API passed the PQ certification audit of who and was posted on the WHO website（ https://extranet.who.int/pqweb/ ）Publicity.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Clock in Beijing McDonald's: McDonald's China launched a series of Spring Festival themed activities
Briefing Jan 05, 2022 10:19 AM
· Healthcare
Breeding stocks continued to strengthen and aonong biology rose by the limit
Healthcare
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
Briefing Aug 31, 2021 08:59 PM
TECO shares: obtained an invention patent certificate
Briefing Aug 26, 2021 08:43 PM
Bandung special assistant responded: the company can not intervene in the personal debt disputes between dormant shareholders and prominent shareholders, but can only promote them laterally
See more
Read next
Insight
In-depth
Insight
In-depth
